Internal Medicine, Medical Oncology · Glenview, IL
NPI
1093752990
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2100 Pfingsten Rd, Kellogg Cancer Care Center
Glenview, IL, 60026
Phone (847) 657-5826
Groups this clinician bills Medicare through
Medicare paid, 2024
$94K
1,657 services
Medicare patients, 2024
549
Average age 76
Drug cost, 2024
$2.1M
1,366 prescriptions
Company payments, 2025
$136
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elaine L Wade was code 99214 (office e&m - established), 676 times for 330 patients. In total Elaine L Wade billed 1,657 services in 14 codes, and Medicare paid $94K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 676 | 330 | $77.62 | $52K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 586 | 403 | $13.53 | $7,930 |
| 99213 Office E&M - Established | Office | 181 | 178 | $50.23 | $9,091 |
| 99215 Office E&M - Established | Office | 125 | 68 | $120.76 | $15K |
| 99205 Office E&M - New | Office | 29 | 29 | $155.20 | $4,501 |
| 99233 Hospital E&M - Subsequent | Facility | 11 | 11 | $100.32 | $1,104 |
By year: 2022 $71K for 1,020 services; 2023 $82K for 1,096 services; 2024 $94K for 1,657 services.
Medicare prescription drug claims, 2024
In 2024, the drug Elaine L Wade prescribed most often to Medicare patients was Letrozole, with 701 prescriptions and refills. In total Elaine L Wade wrote 1,366 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 701 | 2,017 | 204 | $18K |
| Anastrozole Generic | 237 | 678 | 64 | $4,561 |
| Exemestane Generic | 114 | 266 | 26 | $25K |
| Ibrance Palbociclib | 53 | 53 | Under 11 | $829K |
| Gabapentin Generic | 46 | 59 | Under 11 | $189 |
| Kisqali Ribociclib Succinate | 28 | 28 | Under 11 | $385K |
| Ondansetron Hcl Generic | 18 | 18 | 12 | $112 |
| Prochlorperazine Maleate Generic | 15 | 15 | 12 | $68.88 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 14 | 14 | Under 11 | $215 |
| Tramadol Hcl Generic | 13 | 13 | Under 11 | $13.38 |
| Raloxifene Hcl Generic | 13 | 39 | Under 11 | $451 |
Brand drugs: 178 claims; generic drugs: 1,188 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elaine L Wade $136 ($136 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $95.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.